CONTAK RENEWAL
Report
- Report Number
- 2124215-2013-12113
- Event Type
- Injury
- Date Received
- July 29, 2013
- Date of Event
- January 1, 2013
- Report Date
- March 11, 2015
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- NIK
- PMA / PMN Number
- P010012
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
(B)(4). UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. A VISUAL INSPECTION OF THE DEVICE HEADER AND CASE NOTED NO ANOMALIES. THE DEVICE WAS THEN EXPOSED TO SIMULATED HEART LOAD CONDITIONS, AND THE DEFIBRILLATION, PACING AND SENSING FUNCTIONS WERE TESTED. THE DEVICE OPERATED APPROPRIATELY, ACCORDING TO ITS PERFORMANCE SPECIFICATIONS, WITH NO INTERRUPTIONS IN THERAPY OUTPUT OR PROGRAMMER COMMUNICATION AT THE RETURNED PROGRAMMED SETTINGS. A SERIES OF ELECTRICAL TESTS WAS ALSO PERFORMED, AND AGAIN, NORMAL DEVICE FUNCTION WAS OBSERVED. THE CLINICAL OBSERVATIONS WERE NOT ABLE TO BE CONFIRMED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS THIS RIGHT VENTRICULAR (RV) LEAD AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) REPORTED HEARING THEIR DEVICE BEEPING. THE PATIENT WAS SEEN FOR A DEVICE FOLLOW UP WHERE IT WAS DISCOVERED THAT THE DEVICE HAD RECORDED LOW, OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS. THE SHOCKING LEAD IMPEDANCE WAS TESTED AND WAS NORMAL. SUBSEQUENTLY, THE SYSTEM CONTINUED TO DISPLAY LOW, OUT OF RANGE SHOCK MEASUREMENTS. THE PATIENT WAS SEEN AGAIN WHERE SYNCHRONOUS 41 AND 45 JOULE SHOCKS WERE DELIVERED TO ASSES THE INTEGRITY OF THE SYSTEM. THE RESULTING MEASUREMENTS WERE IN RANGE. THE PHYSICIAN WILL CONTINUE TO MONITOR THE PATIENT. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED. THE SYSTEM REMAINS IN SERVICE.
SUBSEQUENT INFORMATION INDICATES THAT THE DEVICE WAS EXPLANTED FOR NORMAL BATTERY DEPLETION. THE DEVICE WAS RETURNED FOR ANALYSIS. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 351879 | CONTAK RENEWAL | IMPLANTABLE CHF GENERATOR | NIK | GUIDANT CRM CLONMEL IRELAND | H179 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Life Threatening| R | H179| 0157| 4087| 4512| H175 |